ZA912037B - Use of il-4 to enhance immune response to infectious antigenic challenges - Google Patents
Use of il-4 to enhance immune response to infectious antigenic challengesInfo
- Publication number
- ZA912037B ZA912037B ZA912037A ZA912037A ZA912037B ZA 912037 B ZA912037 B ZA 912037B ZA 912037 A ZA912037 A ZA 912037A ZA 912037 A ZA912037 A ZA 912037A ZA 912037 B ZA912037 B ZA 912037B
- Authority
- ZA
- South Africa
- Prior art keywords
- immune response
- agents
- inducing
- enhance immune
- mammals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49683290A | 1990-03-21 | 1990-03-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA912037B true ZA912037B (en) | 1992-03-25 |
Family
ID=23974340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA912037A ZA912037B (en) | 1990-03-21 | 1991-03-19 | Use of il-4 to enhance immune response to infectious antigenic challenges |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0521916B1 (xx) |
| JP (1) | JPH05505799A (xx) |
| CN (1) | CN1055116A (xx) |
| AT (1) | ATE133074T1 (xx) |
| AU (1) | AU656889B2 (xx) |
| CA (1) | CA2078676A1 (xx) |
| DE (1) | DE69116552T2 (xx) |
| DK (1) | DK0521916T3 (xx) |
| ES (1) | ES2082201T3 (xx) |
| FI (1) | FI924215A0 (xx) |
| GR (1) | GR3019018T3 (xx) |
| HU (1) | HUT63062A (xx) |
| IE (1) | IE72204B1 (xx) |
| IL (1) | IL97600A0 (xx) |
| MY (1) | MY108672A (xx) |
| OA (1) | OA09672A (xx) |
| PT (1) | PT97082B (xx) |
| WO (1) | WO1991014450A1 (xx) |
| ZA (1) | ZA912037B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100191223B1 (ko) * | 1989-07-28 | 1999-06-15 | 둘락 노먼 씨. | 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물 |
| US5827670A (en) * | 1990-08-02 | 1998-10-27 | Fred Hutchinson Cancer Research Center | Methods of isolating and detecting bone marrow stromal cells with VCAM-1-specific antibodies |
| US7449186B1 (en) | 1990-08-02 | 2008-11-11 | Fred Hutchinson Cancer Research Center | Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies |
| CA2098726A1 (en) * | 1990-12-19 | 1992-06-20 | Edward J. Rozhon | Use of il-4 to enhance immune response to immunogens in vaccines |
| JPH0747545B2 (ja) * | 1991-01-10 | 1995-05-24 | シェリング・コーポレーション | 創傷治癒及び修復の修復段階を促進し、かつ感染した創傷及び糖尿病哺乳類の創傷の治癒を促進するためのｉｌ−４の用途 |
| GB9124347D0 (en) * | 1991-11-15 | 1992-01-08 | Isis Innovation | Treatment of macrophages |
| JP2711182B2 (ja) * | 1992-08-19 | 1998-02-10 | シェリング・コーポレーション | Ｉｌ−４を用いるｈｉｖ複製を阻害する方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL80678A (en) * | 1985-11-19 | 1999-05-09 | Schering Biotech Corp | Human interleukin-4 |
| DE3882611T2 (de) * | 1987-08-03 | 1993-12-23 | Tasuku Honjo | Menschliches Interleukin-4, Expressionsvektoren dafür und diese enthaltende Transformanten. |
| JPH0236129A (ja) * | 1988-07-22 | 1990-02-06 | Ajinomoto Co Inc | ワクチン効果増強剤 |
| EP0454736A4 (en) * | 1989-01-20 | 1993-05-12 | The University Of Melbourne | Fibrinolysis |
-
1991
- 1991-03-19 CA CA002078676A patent/CA2078676A1/en not_active Abandoned
- 1991-03-19 ZA ZA912037A patent/ZA912037B/xx unknown
- 1991-03-19 JP JP91506229A patent/JPH05505799A/ja active Pending
- 1991-03-19 IL IL97600A patent/IL97600A0/xx unknown
- 1991-03-19 EP EP91906129A patent/EP0521916B1/en not_active Expired - Lifetime
- 1991-03-19 HU HU8829D patent/HUT63062A/hu unknown
- 1991-03-19 MY MYPI91000459A patent/MY108672A/en unknown
- 1991-03-19 DE DE69116552T patent/DE69116552T2/de not_active Expired - Fee Related
- 1991-03-19 DK DK91906129.1T patent/DK0521916T3/da active
- 1991-03-19 ES ES91906129T patent/ES2082201T3/es not_active Expired - Lifetime
- 1991-03-19 AT AT91906129T patent/ATE133074T1/de active
- 1991-03-19 WO PCT/US1991/001733 patent/WO1991014450A1/en active IP Right Grant
- 1991-03-19 AU AU74690/91A patent/AU656889B2/en not_active Ceased
- 1991-03-20 CN CN91101850A patent/CN1055116A/zh active Pending
- 1991-03-20 IE IE92191A patent/IE72204B1/en not_active IP Right Cessation
- 1991-03-20 PT PT97082A patent/PT97082B/pt not_active IP Right Cessation
-
1992
- 1992-09-21 FI FI924215A patent/FI924215A0/fi not_active Application Discontinuation
- 1992-09-21 OA OA60278A patent/OA09672A/en unknown
-
1996
- 1996-02-20 GR GR960400419T patent/GR3019018T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| OA09672A (en) | 1993-05-15 |
| CA2078676A1 (en) | 1991-09-22 |
| PT97082A (pt) | 1991-11-29 |
| HUT63062A (en) | 1993-07-28 |
| IE72204B1 (en) | 1997-04-09 |
| IL97600A0 (en) | 1992-06-21 |
| EP0521916B1 (en) | 1996-01-17 |
| EP0521916A1 (en) | 1993-01-13 |
| ATE133074T1 (de) | 1996-02-15 |
| DE69116552T2 (de) | 1996-05-30 |
| PT97082B (pt) | 1998-07-31 |
| MY108672A (en) | 1996-10-31 |
| DE69116552D1 (de) | 1996-02-29 |
| JPH05505799A (ja) | 1993-08-26 |
| IE910921A1 (en) | 1991-09-25 |
| GR3019018T3 (en) | 1996-05-31 |
| WO1991014450A1 (en) | 1991-10-03 |
| ES2082201T3 (es) | 1996-03-16 |
| FI924215A (fi) | 1992-09-21 |
| DK0521916T3 (da) | 1996-03-04 |
| CN1055116A (zh) | 1991-10-09 |
| AU656889B2 (en) | 1995-02-23 |
| AU7469091A (en) | 1991-10-21 |
| FI924215A0 (fi) | 1992-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9304089A (es) | Uso de gm-csf como una vacuna adyuvante. | |
| BR9909915A (pt) | Composições adjuvantes | |
| KR930702022A (ko) | 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법 | |
| EA201001189A1 (ru) | Вакцинные композиции, содержащие сапониновый адъювант | |
| CA2116562A1 (en) | Morphogen-Induced Modulation of Inflammatory Response | |
| AU1813701A (en) | Interleukin-1 muteins useful as vaccine adjuvants | |
| DE3669106D1 (de) | Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe. | |
| ZA912037B (en) | Use of il-4 to enhance immune response to infectious antigenic challenges | |
| DK0563254T3 (da) | Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner | |
| ATE229981T1 (de) | Glykolisierte cytokine | |
| ES2046246T3 (es) | Composicion terapeutica para combatir el sida. | |
| CA2331086A1 (en) | Hepatitis vaccine | |
| EA200301125A1 (ru) | Вакцины, включающие в качестве адъюванта интерферон типа i, и связанные с этим способы | |
| KR960700741A (ko) | 인터페론치료에 대한 무응답자의 c형 간염 치료방법(method of treating hepatitis c in non-pesponders to interferon treatment) | |
| ATE385809T1 (de) | Saponin-zusammensetzungen und deren verwendung | |
| DE69706657D1 (de) | Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen | |
| NZ501427A (en) | Vaccine compositions comprising the Helicobacter pylori FlgE (flagella) polypeptide and a mucosal adjuvant | |
| ITRM910038A1 (it) | Composizioni farmaceutiche aventi come principio attivo calcitonina da somministrarsi per via intranasale. |